EXACT Therapeutics AS (OSL: EXTX)
Norway
· Delayed Price · Currency is NOK 3.400
-0.060 (-1.73%)
At close: Jan 17, 2025
EXACT Therapeutics AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -54.84 | -48.33 | -40.1 | -58.59 | -33.09 | -14.82 | Upgrade
|
| Depreciation & Amortization | 2.23 | 2.09 | 1.94 | 1.83 | 0.9 | 0.4 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.05 | -0.17 | Upgrade
|
| Stock-Based Compensation | 3.34 | 3.96 | -0.4 | 4.16 | 7.85 | - | Upgrade
|
| Other Operating Activities | -0.95 | 0 | -0.21 | -0.52 | -1.66 | 0.01 | Upgrade
|
| Change in Accounts Receivable | -1.53 | -1.32 | -0.53 | -1.62 | -0.9 | -1.24 | Upgrade
|
| Change in Accounts Payable | 6.67 | -0.69 | 5.46 | 0.74 | -0.25 | 3.51 | Upgrade
|
| Change in Other Net Operating Assets | -0.04 | -0 | - | -1.11 | 1.11 | -0.16 | Upgrade
|
| Operating Cash Flow | -45.11 | -44.3 | -33.85 | -55.11 | -25.99 | -12.46 | Upgrade
|
| Capital Expenditures | -3.06 | -3.09 | -0.25 | -1.63 | -3.96 | -1.4 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -0.12 | - | Upgrade
|
| Investment in Securities | - | - | 20.37 | - | 2 | -21.63 | Upgrade
|
| Other Investing Activities | 0.83 | 0.95 | 0.48 | 0.62 | 1.1 | - | Upgrade
|
| Investing Cash Flow | -2.23 | -2.15 | 20.6 | -1.01 | -0.98 | -23.03 | Upgrade
|
| Long-Term Debt Repaid | - | -0.58 | -0.51 | -0.44 | -0.15 | -0.1 | Upgrade
|
| Net Debt Issued (Repaid) | -0.62 | -0.58 | -0.51 | -0.44 | -0.15 | -0.1 | Upgrade
|
| Issuance of Common Stock | 25 | 25 | 0.1 | 0.51 | 146.52 | - | Upgrade
|
| Other Financing Activities | -1.33 | -1.25 | -0.12 | -0.12 | -3.8 | -0.01 | Upgrade
|
| Financing Cash Flow | 23.05 | 23.17 | -0.53 | -0.05 | 142.57 | -0.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.97 | 0.32 | 0.26 | -0.15 | -0.13 | 0.16 | Upgrade
|
| Net Cash Flow | -23.32 | -22.96 | -13.52 | -56.31 | 115.47 | -35.45 | Upgrade
|
| Free Cash Flow | -48.17 | -47.39 | -34.1 | -56.74 | -29.95 | -13.86 | Upgrade
|
| Free Cash Flow Margin | - | -1062987.39% | -7503.15% | -109106.39% | - | -15710.68% | Upgrade
|
| Free Cash Flow Per Share | -1.45 | -1.48 | -1.14 | -1.89 | -1.00 | -0.74 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.09 | 0.1 | 0.1 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -27.24 | -29.35 | -19.34 | -34.63 | -16.96 | -8.72 | Upgrade
|
| Unlevered Free Cash Flow | -27.24 | -29.29 | -19.27 | -34.57 | -16.94 | -8.71 | Upgrade
|
| Change in Net Working Capital | -5.14 | 2.01 | -4.92 | 1.99 | 0.04 | -2.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.